FMP
VanEck Pharmaceutical ETF
PPH
NASDAQ
The fund normally invests at least 80% of its total assets in securities that comprise the fund's benchmark index. The index includes common stocks and depositary receipts of U.S. exchange-listed companies in the pharmaceutical industry. Such companies may include medium-capitalization companies and foreign companies that are listed on a U.S. exchange. It is non-diversified.
85.31 USD
-1.17 (-1.37%)
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
68.8k
45.63k
15.23k
717.85k
1.13M
169.09k
84.55k
42.27k
21.14k
10.57k
-0.78
0.04
-0.01
1.17
0.85
0.25
0.25
0.25
0.25
14.73M
18.1M
19.02M
14.06M
15.51M
-8.29M
-4.14M
-2.07M
-1.04M
-517.91k
-167.95
14.78
-11.1
22.93
11.57
-12.36
-12.36
-12.36
-12.36
-
-
-
14.06M
-
3.07M
1.54M
768.55k
384.27k
192.14k
-
-
-
22.93
-
4.59
4.59
4.59
4.59
17.1M
18.95M
1.1M
4.53M
12.56M
-9.17M
-4.58M
-2.29M
-1.15M
-573.07k
-194.92
15.48
-0.64
7.4
9.37
-13.68
-13.68
-13.68
-13.68
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-